Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Two stage revision with a proximal femur replacement.

Dieckmann R, Schmidt-Braekling T, Gosheger G, Theil C, Hardes J, Moellenbeck B.

BMC Musculoskelet Disord. 2019 Feb 8;20(1):58. doi: 10.1186/s12891-019-2442-2.

2.

Megaprosthetic replacement of the distal humerus: still a challenge in limb salvage.

Henrichs MP, Liem D, Gosheger G, Streitbuerger A, Nottrott M, Andreou D, Hardes J.

J Shoulder Elbow Surg. 2019 Feb 1. pii: S1058-2746(18)30878-4. doi: 10.1016/j.jse.2018.11.050. [Epub ahead of print]

PMID:
30713063
3.

Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone.

Baumhoer D, Kovac M, Sperveslage J, Ameline B, Strobl AC, Krause A, Trautmann M, Wardelmann E, Nathrath M, Höller S, Hardes J, Gosheger G, Krieg AH, Vieth V, Tirabosco R, Amary F, Flanagan AM, Hartmann W.

J Pathol. 2018 Dec 13. doi: 10.1002/path.5216. [Epub ahead of print]

PMID:
30549028
4.

The minimalinvasive direct anterior approach in aseptic cup revision hip arthroplasty: a mid-term follow-up.

Horsthemke MD, Koenig C, Gosheger G, Hardes J, Hoell S.

Arch Orthop Trauma Surg. 2019 Jan;139(1):121-126. doi: 10.1007/s00402-018-3062-2. Epub 2018 Nov 11.

PMID:
30415415
5.

Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma.

Kessler T, Baumeier A, Brand C, Grau M, Angenendt L, Harrach S, Stalmann U, Schmidt LH, Gosheger G, Hardes J, Andreou D, Dreischalück J, Lenz G, Wardelmann E, Mesters RM, Schwöppe C, Berdel WE, Hartmann W, Schliemann C.

Transl Oncol. 2018 Dec;11(6):1271-1282. doi: 10.1016/j.tranon.2018.08.004. Epub 2018 Aug 17.

6.

Impact of the Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study Group on local therapy and overall survival of Ewing sarcoma patients after induction therapy.

Kreyer J, Ranft A, Timmermann B, Juergens H, Jung S, Wiebe K, Boelling T, Schuck A, Vieth V, Streitbuerger A, Hardes J, Heinemann M, Dirksen U.

Pediatr Blood Cancer. 2018 Dec;65(12):e27384. doi: 10.1002/pbc.27384. Epub 2018 Aug 7.

PMID:
30084137
7.

Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy.

Rehkämper J, Steinestel K, Jeiler B, Elges S, Hekeler E, Huss S, Sperveslage J, Hardes J, Streitbürger A, Gosheger G, Wardelmann E, Baumhoer D, Trautmann M, Hartmann W.

Oncotarget. 2018 Jul 10;9(53):30106-30114. doi: 10.18632/oncotarget.25725. eCollection 2018 Jul 10.

8.

Silver-coated megaprostheses in the proximal femur in patients with sarcoma.

Streitbuerger A, Henrichs MP, Hauschild G, Nottrott M, Guder W, Hardes J.

Eur J Orthop Surg Traumatol. 2018 Jun 20. doi: 10.1007/s00590-018-2270-3. [Epub ahead of print]

PMID:
29926243
9.

Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases.

Schliemann C, Kerkhoff A, Hesse P, Bröckling S, Hardes J, Streitbürger A, Andreou D, Gosheger G, Elges S, Wardelmann E, Hartmann W, Mesters R, Lenz G, Willich N, Kriz J, Eich H, Berdel WE, Kessler T.

PLoS One. 2018 May 22;13(5):e0197315. doi: 10.1371/journal.pone.0197315. eCollection 2018.

10.

Tumour endoprosthesis replacement in the proximal tibia after intra-articular knee resection in patients with sarcoma and recurrent giant cell tumour.

Hardes J, Henrichs MP, Gosheger G, Guder W, Nottrott M, Andreou D, Bormann E, Eveslage M, Hauschild G, Streitbürger A.

Int Orthop. 2018 Oct;42(10):2475-2481. doi: 10.1007/s00264-018-3893-z. Epub 2018 Mar 22.

PMID:
29569138
11.

Knochensarkome.

Hardes J, Gosheger G, Budny T.

Z Orthop Unfall. 2018 Feb;156(1):105-124. doi: 10.1055/s-0043-117905. Epub 2018 Feb 22. German.

PMID:
29471560
12.

T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G.

Spurny C, Kailayangiri S, Altvater B, Jamitzky S, Hartmann W, Wardelmann E, Ranft A, Dirksen U, Amler S, Hardes J, Fluegge M, Meltzer J, Farwick N, Greune L, Rossig C.

Oncotarget. 2017 Dec 22;9(5):6536-6549. doi: 10.18632/oncotarget.23815. eCollection 2018 Jan 19.

13.

Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomas.

Spurny C, Kailayangiri S, Jamitzky S, Altvater B, Wardelmann E, Dirksen U, Hardes J, Hartmann W, Rossig C.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26719. Epub 2017 Sep 4.

PMID:
28868758
14.

Silver-Coated Megaprosthesis of the Proximal Tibia in Patients With Sarcoma.

Hardes J, Henrichs MP, Hauschild G, Nottrott M, Guder W, Streitbuerger A.

J Arthroplasty. 2017 Jul;32(7):2208-2213. doi: 10.1016/j.arth.2017.02.054. Epub 2017 Mar 1.

15.

Silver-coated megaprostheses: review of the literature.

Schmidt-Braekling T, Streitbuerger A, Gosheger G, Boettner F, Nottrott M, Ahrens H, Dieckmann R, Guder W, Andreou D, Hauschild G, Moellenbeck B, Waldstein W, Hardes J.

Eur J Orthop Surg Traumatol. 2017 May;27(4):483-489. doi: 10.1007/s00590-017-1933-9. Epub 2017 Mar 6. Review.

PMID:
28265758
16.

Bilateral Scapulothoracic Osteochondromas in a Patient With Hereditary Multiple Exostosis: A Case Report and Review of the Literature.

Rupp M, Hardes J, Raschke MJ, Skwara A.

Orthop Rev (Pavia). 2016 Sep 19;8(3):6501. eCollection 2016 Sep 19.

17.

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.

Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PCW, Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens MCG, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS.

Lancet Oncol. 2016 Oct;17(10):1396-1408. doi: 10.1016/S1470-2045(16)30214-5. Epub 2016 Aug 25.

18.

Eradication rates, risk factors, and implant selection in two-stage revision knee arthroplasty: a mid-term follow-up study.

Hoell S, Sieweke A, Gosheger G, Hardes J, Dieckmann R, Ahrens H, Streitbuerger A.

J Orthop Surg Res. 2016 Aug 26;11(1):93. doi: 10.1186/s13018-016-0428-4.

19.

Forequarter amputation: a safe rescue procedure in a curative and palliative setting in high-grade malignoma of the shoulder girdle.

Elsner U, Henrichs M, Gosheger G, Dieckmann R, Nottrott M, Hardes J, Streitbürger A.

World J Surg Oncol. 2016 Aug 15;14(1):216. doi: 10.1186/s12957-016-0973-7.

20.

Knee salvage in revision arthroplasty after massive bone loss of the femur condyles (≥Engh III) with a single-modular-hinged knee revision implant.

Streitbuerger A, Hardes J, Gosheger G, Dieckmann R, Hoell S.

Arch Orthop Trauma Surg. 2016 Aug;136(8):1077-83. doi: 10.1007/s00402-016-2491-z. Epub 2016 Jul 1.

PMID:
27370883

Supplemental Content

Loading ...
Support Center